Taken together, these results indicate that the combination of BETi/MEKi perturbs the cell cycle machinery and activates apoptotic signaling in NRAS‐mutant melanoma cells in part by synergistically downregulating the PHD‐type zinc finger domain containing transcription factor TCF19. The gene discussed is TCF19; the disease is melanoma.